TTrialPathMatch Me to Trials
← Back to trials
RecruitingGynecologic DiseaseGynecologic CancerEndometriosis

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Eligible age

18+ yrs

Accepts

Women

Locations

0 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

GynRAN is an international, multicentre, transversal, diagnostic and non-interventional study carried out in gynecology-obstetrics/gynecological oncology departments that aims to identify a diagnostic signature for gynecological pathologies by analyzing of coding and non-coding RNA contained in patients saliva. The study population consists of patients with clinically symptomatic females with one or more of the gynecological pathologies (endometriosis, adenomyosis, ovarian cysts, fibroids, ovarian/cervical/uterine cancer) and asymptomatic females. The patients concerned by the study will be managed without modification of the care pathway, nor modification of the therapeutic indications, nor modification of the diagnostic or follow-up examinations necessary according to the context, which are carried out according to the local recommendations.

Sponsor: ZIWIG

You may qualify if…

  • 1. Subject of legal age (according to local legislation) and at least 18 years old
  • 2. Subject (and if applicable her legal representative) having dated and signed the informed consent form
  • 3. Subject with a medical insurance policy
  • 4. Subject presenting to the department:
  • 1. With Symptoms (bleeding and/or pain and/or clinically observed symptom) of one or more of the following pathologies (suspected undergoing diagnostic surgery/biopsy or diagnosed and before any curative treatment of the pathology):
  • Endometriosis
  • Adenomyosis,
  • Ovarian cysts,

You may not qualify if…

  • 1. Recent (\<1 month) or ongoing bacterial or viral infection
  • 2. Known active oral or digestive mycosis
  • 3. Evolving oral pathology, symptomatic or obvious
  • 4. Known pregnancy
  • 5. Known current non-gynecological pelvic pathology
  • 6. Subject with a diagnosed breast cancer or cancer other than gynecological with the exception of basal cell carcinoma
  • 7. Subject with a history of treated cancer within the last 5 years with the exception of basal cell carcinoma
  • 8. Subject who has already received chemotherapy or radiotherapy or undergone complete or partial excision of the gynecological pathology of inclusion criterion

Source: ClinicalTrials.gov · NCT06392997 · last updated 2025-01-23

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gyn · TrialPath